{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:06:03Z","timestamp":1768619163078,"version":"3.49.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00592-018-1137-8","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T13:46:50Z","timestamp":1522849610000},"page":"763-779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7066-5292","authenticated-orcid":false,"given":"Caterina","family":"Conte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Secchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"issue":"9","key":"1137_CR1","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/tri.12807","volume":"29","author":"T Dienemann","year":"2016","unstructured":"Dienemann T, Fujii N, Li Y, Govani S, Kosaraju N, Bloom RD, Feldman HI (2016) Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective study. Transpl Int 29(9):1017\u20131028. \n                    https:\/\/doi.org\/10.1111\/tri.12807","journal-title":"Transpl Int"},{"issue":"1","key":"1137_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nrneph.2011.174","volume":"8","author":"A Sharif","year":"2011","unstructured":"Sharif A, Baboolal K (2011) Complications associated with new-onset diabetes after kidney transplantation. Nat Rev Nephrol 8(1):34\u201342. \n                    https:\/\/doi.org\/10.1038\/nrneph.2011.174","journal-title":"Nat Rev Nephrol"},{"key":"1137_CR3","doi-asserted-by":"publisher","first-page":"8735782","DOI":"10.1155\/2016\/8735782","volume":"2016","author":"A Sheu","year":"2016","unstructured":"Sheu A, Depczynski B, O\u2019Sullivan AJ, Luxton G, Mangos G (2016) The effect of different glycaemic states on renal transplant outcomes. J Diabetes Res 2016:8735782. \n                    https:\/\/doi.org\/10.1155\/2016\/8735782","journal-title":"J Diabetes Res"},{"key":"1137_CR4","volume-title":"Experience in renal transplantation","author":"TE Starzl","year":"1964","unstructured":"Starzl TE (1964) Experience in renal transplantation. W. B. Saunders Company, Philadelphia"},{"issue":"1","key":"1137_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2337\/diacare.6.1.23","volume":"6","author":"P Arner","year":"1983","unstructured":"Arner P, Gunnarsson R, Blomdahl S, Groth CG (1983) Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care 6(1):23\u201325","journal-title":"Diabetes Care"},{"issue":"7879","key":"1137_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S0140-6736(74)92016-9","volume":"2","author":"CM Hill","year":"1974","unstructured":"Hill CM, Douglas JF, Rajkumar KV, McEvoy J, McGeown MG (1974) Glycosuria and hyperglycaemia after kidney transplantation. Lancet 2(7879):490\u2013492","journal-title":"Lancet"},{"key":"1137_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.12659\/AOT.903079","volume":"22","author":"PW Baron","year":"2017","unstructured":"Baron PW, Infante S, Peters R, Tilahun J, Weissman J, Delgado L, Kore AH, Beeson WL, de Vera ME (2017) Post-transplant diabetes mellitus after kidney transplant in hispanics and caucasians treated with tacrolimus-based immunosuppression. Ann Transplant 22:309\u2013314","journal-title":"Ann Transplant"},{"key":"1137_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13040","author":"DC Cron","year":"2017","unstructured":"Cron DC, Noon KA, Cote DR, Terjimanian MN, Augustine JJ, Wang SC, Englesbe MJ, Woodside KJ (2017) Using analytic morphomics to describe body composition associated with post-kidney transplantation diabetes mellitus. Clin Transplant. \n                    https:\/\/doi.org\/10.1111\/ctr.13040","journal-title":"Clin Transplant"},{"issue":"2","key":"1137_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1053\/j.jrn.2013.11.002","volume":"24","author":"TJ Cullen","year":"2014","unstructured":"Cullen TJ, McCarthy MP, Lasarev MR, Barry JM, Stadler DD (2014) Body mass index and the development of new-onset diabetes mellitus or the worsening of pre-existing diabetes mellitus in adult kidney transplant patients. J Ren Nutr 24(2):116\u2013122. \n                    https:\/\/doi.org\/10.1053\/j.jrn.2013.11.002","journal-title":"J Ren Nutr"},{"issue":"1","key":"1137_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/01.tp.0000267647.03550.22","volume":"84","author":"E David-Neto","year":"2007","unstructured":"David-Neto E, Lemos FC, Fadel LM, Agena F, Sato MY, Coccuza C, Pereira LM, de Castro MC, Lando VS, Nahas WC, Ianhez LE (2007) The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients. Transplantation 84(1):50\u201355. \n                    https:\/\/doi.org\/10.1097\/01.tp.0000267647.03550.22","journal-title":"Transplantation"},{"issue":"3","key":"1137_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2337\/dc06-1277","volume":"30","author":"KY Hur","year":"2007","unstructured":"Hur KY, Kim MS, Kim YS, Kang ES, Nam JH, Kim SH, Nam CM, Ahn CW, Cha BS, Kim SI, Lee HC (2007) Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care 30(3):609\u2013615. \n                    https:\/\/doi.org\/10.2337\/dc06-1277","journal-title":"Diabetes Care"},{"issue":"2","key":"1137_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","volume":"3","author":"BL Kasiske","year":"2003","unstructured":"Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ (2003) Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3(2):178\u2013185","journal-title":"Am J Transplant"},{"issue":"8","key":"1137_CR13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/TP.0b013e31816b16bd","volume":"85","author":"E Porrini","year":"2008","unstructured":"Porrini E, Moreno JM, Osuna A, Benitez R, Lampreabe I, Diaz JM, Silva I, Dominguez R, Gonzalez-Cotorruelo J, Bayes B, Lauzurica R, Ibernon M, Moreso F, Delgado P, Torres A (2008) Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study. Transplantation 85(8):1133\u20131138. \n                    https:\/\/doi.org\/10.1097\/TP.0b013e31816b16bd","journal-title":"Transplantation"},{"issue":"2","key":"1137_CR14","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1046\/j.1523-1755.2001.059002732.x","volume":"59","author":"FG Cosio","year":"2001","unstructured":"Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM (2001) Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 59(2):732\u2013737. \n                    https:\/\/doi.org\/10.1046\/j.1523-1755.2001.059002732.x","journal-title":"Kidney Int"},{"issue":"3","key":"1137_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/TP.0b013e318203c25f","volume":"91","author":"FL Luan","year":"2011","unstructured":"Luan FL, Steffick DE, Ojo AO (2011) New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression. Transplantation 91(3):334\u2013341. \n                    https:\/\/doi.org\/10.1097\/TP.0b013e318203c25f","journal-title":"Transplantation"},{"issue":"6","key":"1137_CR16","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.ekir.2017.06.006","volume":"2","author":"J Shin","year":"2017","unstructured":"Shin J, Palta M, Djamali A, Astor BC (2017) Higher pretransplantation hemoglobin A1c is associated with greater risk of posttransplant diabetes mellitus. Kidney Int Rep 2(6):1076\u20131087. \n                    https:\/\/doi.org\/10.1016\/j.ekir.2017.06.006","journal-title":"Kidney Int Rep"},{"issue":"9","key":"1137_CR17","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1111\/ajt.12850","volume":"14","author":"A Sharif","year":"2014","unstructured":"Sharif A, Hecking M, de Vries AP, Porrini E, Hornum M, Rasoul-Rockenschaub S, Berlakovich G, Krebs M, Kautzky-Willer A, Schernthaner G, Marchetti P, Pacini G, Ojo A, Takahara S, Larsen JL, Budde K, Eller K, Pascual J, Jardine A, Bakker SJ, Valderhaug TG, Jenssen TG, Cohney S, Saemann MD (2014) Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant 14(9):1992\u20132000. \n                    https:\/\/doi.org\/10.1111\/ajt.12850","journal-title":"Am J Transplant"},{"issue":"3","key":"1137_CR18","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/sj.ki.5000116","volume":"69","author":"J Hjelmesaeth","year":"2006","unstructured":"Hjelmesaeth J, Hartmann A, Leivestad T, Holdaas H, Sagedal S, Olstad M, Jenssen T (2006) The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 69(3):588\u2013595. \n                    https:\/\/doi.org\/10.1038\/sj.ki.5000116","journal-title":"Kidney Int"},{"issue":"2","key":"1137_CR19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1523-1755.2005.67132.x","volume":"67","author":"AM Mattos de","year":"2005","unstructured":"de Mattos AM, Olyaei AJ, Prather JC, Golconda MS, Barry JM, Norman DJ (2005) Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int 67(2):714\u2013720. \n                    https:\/\/doi.org\/10.1111\/j.1523-1755.2005.67132.x","journal-title":"Kidney Int"},{"issue":"1","key":"1137_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/01.tp.0000248759.37146.3d","volume":"83","author":"RA Hamer","year":"2007","unstructured":"Hamer RA, Chow CL, Ong AC, McKane WS (2007) Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 83(1):36\u201340. \n                    https:\/\/doi.org\/10.1097\/01.tp.0000248759.37146.3d","journal-title":"Transplantation"},{"issue":"1","key":"1137_CR21","doi-asserted-by":"publisher","first-page":"e0147323","DOI":"10.1371\/journal.pone.0147323","volume":"11","author":"KA Benson","year":"2016","unstructured":"Benson KA, Maxwell AP, McKnight AJ (2016) A HuGE review and meta-analyses of genetic associations in new onset diabetes after kidney transplantation. PLoS ONE 11(1):e0147323. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0147323","journal-title":"PLoS ONE"},{"issue":"6","key":"1137_CR22","doi-asserted-by":"publisher","first-page":"e99406","DOI":"10.1371\/journal.pone.0099406","volume":"9","author":"C Lv","year":"2014","unstructured":"Lv C, Chen M, Xu M, Xu G, Zhang Y, He S, Xue M, Gao J, Yu M, Gao X, Zhu T (2014) Influencing factors of new-onset diabetes after a renal transplant and their effects on complications and survival rate. PLoS ONE 9(6):e99406. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0099406","journal-title":"PLoS ONE"},{"issue":"4","key":"1137_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S2213-8587(15)00387-3","volume":"4","author":"A Sharif","year":"2016","unstructured":"Sharif A, Cohney S (2016) Post-transplantation diabetes-state of the art. Lancet Diabetes Endocrinol 4(4):337\u2013349. \n                    https:\/\/doi.org\/10.1016\/S2213-8587(15)00387-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"1137_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/tri.12697","volume":"29","author":"A Fur Le","year":"2016","unstructured":"Le Fur A, Fournier MC, Gillaizeau F, Masson D, Giral M, Cariou B, Cantarovich D, Dantal J (2016) Vitamin D deficiency is an independent risk factor for PTDM after kidney transplantation. Transpl Int 29(2):207\u2013215. \n                    https:\/\/doi.org\/10.1111\/tri.12697","journal-title":"Transpl Int"},{"issue":"2","key":"1137_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/dmrr.2486","volume":"30","author":"JL Hwang","year":"2014","unstructured":"Hwang JL, Weiss RE (2014) Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev 30(2):96\u2013102. \n                    https:\/\/doi.org\/10.1002\/dmrr.2486","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"1137_CR26","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/01.tp.0000203894.53714.27","volume":"81","author":"G Ciancio","year":"2006","unstructured":"Ciancio G, Burke GW, Gaynor JJ, Ruiz P, Roth D, Kupin W, Rosen A, Miller J (2006) A randomized long-term trial of tacrolimus\/sirolimus versus tacrolimums\/mycophenolate versus cyclosporine\/sirolimus in renal transplantation: three-year analysis. Transplantation 81(6):845\u2013852. \n                    https:\/\/doi.org\/10.1097\/01.tp.0000203894.53714.27","journal-title":"Transplantation"},{"issue":"6","key":"1137_CR27","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1093\/ndt\/gfp778","volume":"25","author":"H Ekberg","year":"2010","unstructured":"Ekberg H, Bernasconi C, Noldeke J, Yussim A, Mjornstedt L, Erken U, Ketteler M, Navratil P (2010) Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the symphony study. Nephrol Dial Transplant 25(6):2004\u20132010. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfp778","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"1137_CR28","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/00007890-199610150-00005","volume":"62","author":"DA Laskow","year":"1996","unstructured":"Laskow DA, Vincenti F, Neylan JF, Mendez R, Matas AJ (1996) An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation 62(7):900\u2013905","journal-title":"Transplantation"},{"issue":"6","key":"1137_CR29","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","volume":"7","author":"F Vincenti","year":"2007","unstructured":"Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N, Investigators D (2007) Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7(6):1506\u20131514. \n                    https:\/\/doi.org\/10.1111\/j.1600-6143.2007.01749.x","journal-title":"Am J Transplant"},{"issue":"5","key":"1137_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1034\/j.1600-6143.2003.00082.x","volume":"3","author":"RS Woodward","year":"2003","unstructured":"Woodward RS, Schnitzler MA, Baty J, Lowell JA, Lopez-Rocafort L, Haider S, Woodworth TG, Brennan DC (2003) Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 3(5):590\u2013598","journal-title":"Am J Transplant"},{"issue":"1","key":"1137_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/cpt.546","volume":"101","author":"HA Chakkera","year":"2017","unstructured":"Chakkera HA, Kudva Y, Kaplan B (2017) Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus. Clin Pharmacol Ther 101(1):114\u2013120. \n                    https:\/\/doi.org\/10.1002\/cpt.546","journal-title":"Clin Pharmacol Ther"},{"key":"1137_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001722","author":"B Verges","year":"2017","unstructured":"Verges B (2017) mTOR and cardiovascular diseases: diabetes mellitus. Transplantation. \n                    https:\/\/doi.org\/10.1097\/TP.0000000000001722","journal-title":"Transplantation"},{"issue":"12","key":"1137_CR33","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/ndt\/gfw226","volume":"31","author":"M Huber","year":"2016","unstructured":"Huber M, Kemmner S, Renders L, Heemann U (2016) Should belatacept be the centrepiece of renal transplantation? Nephrol Dial Transplant 31(12):1995\u20132002. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfw226","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1137_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1573399811666150331160846","volume":"11","author":"N Montero","year":"2015","unstructured":"Montero N, Pascual J (2015) Immunosuppression and post-transplant hyperglycemia. Curr Diabetes Rev 11(3):144\u2013154","journal-title":"Curr Diabetes Rev"},{"issue":"Suppl 1","key":"1137_CR35","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1007\/s00592-011-0368-8","volume":"49","author":"R Gallo","year":"2012","unstructured":"Gallo R, Natale M, Vendrame F, Boggi U, Filipponi F, Marchetti P, Laghi Pasini F, Dotta F (2012) In vitro effects of mycophenolic acid on survival, function, and gene expression of pancreatic beta-cells. Acta Diabetol 49(Suppl 1):S123\u2013S131. \n                    https:\/\/doi.org\/10.1007\/s00592-011-0368-8","journal-title":"Acta Diabetol"},{"key":"1137_CR36","doi-asserted-by":"publisher","first-page":"CD004759","DOI":"10.1002\/14651858.cd004759.pub2","volume":"1","author":"P Hill","year":"2017","unstructured":"Hill P, Cross NB, Barnett AN, Palmer SC, Webster AC (2017) Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. Cochrane Database Syst Rev 1:CD004759. \n                    https:\/\/doi.org\/10.1002\/14651858.cd004759.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1137_CR37","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2215\/CJN.05471008","volume":"4","author":"HA Chakkera","year":"2009","unstructured":"Chakkera HA, Weil EJ, Castro J, Heilman RL, Reddy KS, Mazur MJ, Hamawi K, Mulligan DC, Moss AA, Mekeel KL, Cosio FG, Cook CB (2009) Hyperglycemia during the immediate period after kidney transplantation. Clin J Am Soc Nephrol CJASN 4(4):853\u2013859. \n                    https:\/\/doi.org\/10.2215\/CJN.05471008","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"4","key":"1137_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1681\/ASN.2011080835","volume":"23","author":"M Hecking","year":"2012","unstructured":"Hecking M, Haidinger M, Doller D, Werzowa J, Tura A, Zhang J, Tekoglu H, Pleiner J, Wrba T, Rasoul-Rockenschaub S, Muhlbacher F, Schmaldienst S, Druml W, Horl WH, Krebs M, Wolzt M, Pacini G, Port FK, Saemann MD (2012) Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J Am Soc Nephrology JASN 23(4):739\u2013749. \n                    https:\/\/doi.org\/10.1681\/ASN.2011080835","journal-title":"J Am Soc Nephrology JASN"},{"issue":"9","key":"1137_CR39","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.2215\/CJN.09481209","volume":"5","author":"HA Chakkera","year":"2010","unstructured":"Chakkera HA, Knowler WC, Devarapalli Y, Weil EJ, Heilman RL, Dueck A, Mulligan DC, Reddy KS, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Castro JC, Cook CB (2010) Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus. Clin J Am Soc Nephrol CJASN 5(9):1669\u20131675. \n                    https:\/\/doi.org\/10.2215\/CJN.09481209","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"6","key":"1137_CR40","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1093\/ndt\/gfm875","volume":"23","author":"DR Kuypers","year":"2008","unstructured":"Kuypers DR, Claes K, Bammens B, Evenepoel P, Vanrenterghem Y (2008) Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM). Nephrol Dial Transplant 23(6):2033\u20132042. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfm875","journal-title":"Nephrol Dial Transplant"},{"issue":"Supplement 1","key":"1137_CR41","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc18-Sint01","volume":"41","author":"AD Association","year":"2018","unstructured":"Association AD (2018) Standards of Medical Care in Diabetes\u20142018. Diabetes Care 41(Supplement 1):S1\u2013S159","journal-title":"Diabetes Care"},{"issue":"3","key":"1137_CR42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/TP.0b013e3181af1f53","volume":"88","author":"TG Valderhaug","year":"2009","unstructured":"Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J (2009) Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation 88(3):429\u2013434. \n                    https:\/\/doi.org\/10.1097\/TP.0b013e3181af1f53","journal-title":"Transplantation"},{"issue":"6","key":"1137_CR43","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1111\/j.1523-1755.2005.00349.x","volume":"67","author":"FG Cosio","year":"2005","unstructured":"Cosio FG, Kudva Y, van der Velde M, Larson TS, Textor SC, Griffin MD, Stegall MD (2005) New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 67(6):2415\u20132421. \n                    https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00349.x","journal-title":"Kidney Int"},{"issue":"6","key":"1137_CR44","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00125-011-2105-9","volume":"54","author":"TG Valderhaug","year":"2011","unstructured":"Valderhaug TG, Hjelmesaeth J, Hartmann A, Roislien J, Bergrem HA, Leivestad T, Line PD, Jenssen T (2011) The association of early post-transplant glucose levels with long-term mortality. Diabetologia 54(6):1341\u20131349. \n                    https:\/\/doi.org\/10.1007\/s00125-011-2105-9","journal-title":"Diabetologia"},{"issue":"3","key":"1137_CR45","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/ndt\/gfw437","volume":"32","author":"AL Pimentel","year":"2017","unstructured":"Pimentel AL, Cavagnolli G, Camargo JL (2017) Diagnostic accuracy of glycated hemoglobin for post-transplantation diabetes mellitus after kidney transplantation: systematic review and meta-analysis. Nephrol Dial Transplant 32(3):565\u2013572. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfw437","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1137_CR46","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/00007890-199203000-00014","volume":"53","author":"AV Ekstrand","year":"1992","unstructured":"Ekstrand AV, Eriksson JG, Gronhagen-Riska C, Ahonen PJ, Groop LC (1992) Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 53(3):563\u2013569","journal-title":"Transplantation"},{"issue":"10","key":"1137_CR47","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1093\/ndt\/gfg338","volume":"18","author":"M Hagen","year":"2003","unstructured":"Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A (2003) A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant 18(10):2154\u20132159. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfg338","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"1137_CR48","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.2337\/dc12-2441","volume":"36","author":"M Hecking","year":"2013","unstructured":"Hecking M, Kainz A, Werzowa J, Haidinger M, Doller D, Tura A, Karaboyas A, Horl WH, Wolzt M, Sharif A, Roden M, Moro E, Pacini G, Port FK, Saemann MD (2013) Glucose metabolism after renal transplantation. Diabetes Care 36(9):2763\u20132771. \n                    https:\/\/doi.org\/10.2337\/dc12-2441","journal-title":"Diabetes Care"},{"issue":"10","key":"1137_CR49","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1097\/00007890-200105270-00011","volume":"71","author":"JH Nam","year":"2001","unstructured":"Nam JH, Mun JI, Kim SI, Kang SW, Choi KH, Park K, Ahn CW, Cha BS, Song YD, Lim SK, Kim KR, Lee HC, Huh KB (2001) beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 71(10):1417\u20131423","journal-title":"Transplantation"},{"issue":"3","key":"1137_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/tri.12907","volume":"30","author":"MB Jorgensen","year":"2017","unstructured":"Jorgensen MB, Hornum M, van Hall G, Bistrup C, Hansen JM, Mathiesen ER, Feldt-Rasmussen B (2017) The impact of kidney transplantation on insulin sensitivity. Transpl Int 30(3):295\u2013304. \n                    https:\/\/doi.org\/10.1111\/tri.12907","journal-title":"Transpl Int"},{"issue":"9","key":"1137_CR51","doi-asserted-by":"publisher","first-page":"894","DOI":"10.4158\/EP13463.or","volume":"20","author":"SC Ramirez","year":"2014","unstructured":"Ramirez SC, Maaske J, Kim Y, Neagu V, DeLange S, Mazhari A, Gao W, Emanuele MA, Emanuele N, Baldwin D, Mihailescu DV (2014) The association between glycemic control and clinical outcomes after kidney transplantation. Endocr Pract 20(9):894\u2013900. \n                    https:\/\/doi.org\/10.4158\/EP13463.or","journal-title":"Endocr Pract"},{"issue":"12","key":"1137_CR52","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1210\/jc.2012-1979","volume":"97","author":"KL Hermayer","year":"2012","unstructured":"Hermayer KL, Egidi MF, Finch NJ, Baliga P, Lin A, Kettinger L, Biggins S, Carter RE (2012) A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. J Clin Endocrinol Metab 97(12):4399\u20134406. \n                    https:\/\/doi.org\/10.1210\/jc.2012-1979","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"1137_CR53","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","volume":"9","author":"Kidney Disease: Improving Global Outcomes Transplant Work G","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes Transplant Work G (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9(Suppl 3):S1\u2013S155. \n                    https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02834.x","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"1137_CR54","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.2337\/dc17-s009","volume":"40","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association (2017) 6. Glycemic targets. Diabetes Care 40(Suppl 1):S48\u2013S56. \n                    https:\/\/doi.org\/10.2337\/dc17-s009","journal-title":"Diabetes Care"},{"issue":"8","key":"1137_CR55","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/01.tp.0000259617.21741.95","volume":"83","author":"TE Burroughs","year":"2007","unstructured":"Burroughs TE, Swindle J, Takemoto S, Lentine KL, Machnicki G, Irish WD, Brennan DC, Schnitzler MA (2007) Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation 83(8):1027\u20131034. \n                    https:\/\/doi.org\/10.1097\/01.tp.0000259617.21741.95","journal-title":"Transplantation"},{"issue":"5","key":"1137_CR56","doi-asserted-by":"publisher","first-page":"E1024","DOI":"10.1152\/ajpendo.00056.2004","volume":"287","author":"F Dela","year":"2004","unstructured":"Dela F, von Linstow ME, Mikines KJ, Galbo H (2004) Physical training may enhance beta-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab 287(5):E1024\u2013E1031. \n                    https:\/\/doi.org\/10.1152\/ajpendo.00056.2004","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"1137_CR57","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.2337\/dc09-2021","volume":"33","author":"TP Solomon","year":"2010","unstructured":"Solomon TP, Haus JM, Kelly KR, Rocco M, Kashyap SR, Kirwan JP (2010) Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care 33(7):1561\u20131566. \n                    https:\/\/doi.org\/10.2337\/dc09-2021","journal-title":"Diabetes Care"},{"issue":"1","key":"1137_CR58","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12882-017-0709-0","volume":"18","author":"G Klaassen","year":"2017","unstructured":"Klaassen G, Zelle DM, Navis GJ, Dijkema D, Bemelman FJ, Bakker SJL, Corpeleijn E (2017) Lifestyle intervention to improve quality of life and prevent weight gain after renal transplantation: design of the active care after transplantation (ACT) randomized controlled trial. BMC Nephrol 18(1):296. \n                    https:\/\/doi.org\/10.1186\/s12882-017-0709-0","journal-title":"BMC Nephrol"},{"issue":"1","key":"1137_CR59","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s13063-017-2158-2","volume":"18","author":"EF Pedrollo","year":"2017","unstructured":"Pedrollo EF, Nicoletto BB, Carpes LS, de Freitas JMC, Buboltz JR, Forte CC, Bauer AC, Manfro RC, Souza GC, Leitao CB (2017) Effect of an intensive nutrition intervention of a high protein and low glycemic-index diet on weight of kidney transplant recipients: study protocol for a randomized clinical trial. Trials 18(1):413. \n                    https:\/\/doi.org\/10.1186\/s13063-017-2158-2","journal-title":"Trials"},{"key":"1137_CR60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s13063-016-1543-6","volume":"17","author":"J Wilcox","year":"2016","unstructured":"Wilcox J, Waite C, Tomlinson L, Driscoll J, Karim A, Day E, Sharif A (2016) Comparing glycaemic benefits of active versus passive lifestyle Intervention in kidney allograft recipients (CAVIAR): study protocol for a randomised controlled trial. Trials 17:417. \n                    https:\/\/doi.org\/10.1186\/s13063-016-1543-6","journal-title":"Trials"},{"key":"1137_CR61","doi-asserted-by":"publisher","first-page":"CD009966","DOI":"10.1002\/14651858.cd009966.pub2","volume":"2","author":"C Lo","year":"2017","unstructured":"Lo C, Jun M, Badve SV, Pilmore H, White SL, Hawley C, Cass A, Perkovic V, Zoungas S (2017) Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. Cochrane Database Syst Rev 2:CD009966. \n                    https:\/\/doi.org\/10.1002\/14651858.cd009966.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"1137_CR62","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.2337\/dc17-s011","volume":"40","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association (2017) 8. Pharmacologic Approaches to Glycemic Treatment. Diabetes Care 40(Suppl 1):S64\u2013S74. \n                    https:\/\/doi.org\/10.2337\/dc17-s011","journal-title":"Diabetes Care"},{"issue":"9","key":"1137_CR63","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena G, Hardie DG, Pearson ER (2017) The mechanisms of action of metformin. Diabetologia 60(9):1577\u20131585. \n                    https:\/\/doi.org\/10.1007\/s00125-017-4342-z","journal-title":"Diabetologia"},{"key":"1137_CR64","unstructured":"European Medicines Agency (2016) Use of metformin to treat diabetes now expanded to patients with moderately reduced kidney function. Available at \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Metformin_31\/WC500214235.pdf"},{"issue":"6","key":"1137_CR65","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1159\/000370034","volume":"40","author":"J Stephen","year":"2014","unstructured":"Stephen J, Anderson-Haag TL, Gustafson S, Snyder JJ, Kasiske BL, Israni AK (2014) Metformin use in kidney transplant recipients in the United States: an observational study. Am J Nephrol 40(6):546\u2013553. \n                    https:\/\/doi.org\/10.1159\/000370034","journal-title":"Am J Nephrol"},{"issue":"8","key":"1137_CR66","doi-asserted-by":"publisher","first-page":"979","DOI":"10.4158\/EP.14.8.979","volume":"14","author":"B Kurian","year":"2008","unstructured":"Kurian B, Joshi R, Helmuth A (2008) Effectiveness and long-term safety of thiazolidinediones and metformin in renal transplant recipients. Endocr Pract 14(8):979\u2013984. \n                    https:\/\/doi.org\/10.4158\/EP.14.8.979","journal-title":"Endocr Pract"},{"issue":"2","key":"1137_CR67","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.trre.2016.09.001","volume":"31","author":"T Vanhove","year":"2017","unstructured":"Vanhove T, Remijsen Q, Kuypers D, Gillard P (2017) Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus. Transplant Rev 31(2):69\u201377. \n                    https:\/\/doi.org\/10.1016\/j.trre.2016.09.001","journal-title":"Transplant Rev"},{"issue":"5","key":"1137_CR68","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2337\/dc16-1943","volume":"40","author":"L Azoulay","year":"2017","unstructured":"Azoulay L, Suissa S (2017) Sulfonylureas and the risks of cardiovascular events and death: a methodological meta-regression analysis of the observational studies. Diabetes Care 40(5):706\u2013714. \n                    https:\/\/doi.org\/10.2337\/dc16-1943","journal-title":"Diabetes Care"},{"issue":"23","key":"1137_CR69","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/nejmoa066224","volume":"355","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, Oneill MC, Zinman B, Viberti G, Group AS (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355(23):2427\u20132443. \n                    https:\/\/doi.org\/10.1056\/nejmoa066224","journal-title":"N Engl J Med"},{"issue":"1","key":"1137_CR70","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jdiacomp.2004.05.001","volume":"19","author":"S Guerra Del","year":"2005","unstructured":"Del Guerra S, Marselli L, Lupi R, Boggi U, Mosca F, Benzi L, Del Prato S, Marchetti P (2005) Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets. J Diabetes Complicat 19(1):60\u201364. \n                    https:\/\/doi.org\/10.1016\/j.jdiacomp.2004.05.001","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"1137_CR71","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1210\/jc.2004-0699","volume":"90","author":"K Maedler","year":"2005","unstructured":"Maedler K, Carr RD, Bosco D, Zuellig RA, Berney T, Donath MY (2005) Sulfonylurea induced beta-cell apoptosis in cultured human islets. J Clin Endocrinol Metab 90(1):501\u2013506. \n                    https:\/\/doi.org\/10.1210\/jc.2004-0699","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1137_CR72","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1517\/17425255.2013.777428","volume":"9","author":"AJ Scheen","year":"2013","unstructured":"Scheen AJ (2013) Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease. Exp Opin Drug Metab Toxicol 9(5):529\u2013550. \n                    https:\/\/doi.org\/10.1517\/17425255.2013.777428","journal-title":"Exp Opin Drug Metab Toxicol"},{"issue":"5","key":"1137_CR73","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/ctr.12541","volume":"29","author":"M Haidinger","year":"2015","unstructured":"Haidinger M, Antlanger M, Kopecky C, Kovarik JJ, Saemann MD, Werzowa J (2015) Post-transplantation diabetes mellitus: evaluation of treatment strategies. Clin Transplant 29(5):415\u2013424. \n                    https:\/\/doi.org\/10.1111\/ctr.12541","journal-title":"Clin Transplant"},{"issue":"1","key":"1137_CR74","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5414\/CNP70026","volume":"70","author":"TR Tuerk","year":"2008","unstructured":"Tuerk TR, Bandur S, Nuernberger J, Kribben A, Mann K, Philipp T, Heemann U, Viklicky O, Witzke O (2008) Gliquidone therapy of new-onset diabetes mellitus after kidney transplantation. Clin Nephrol 70(1):26\u201332","journal-title":"Clin Nephrol"},{"issue":"4","key":"1137_CR75","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1600-6143.2006.01250.x","volume":"6","author":"T Turk","year":"2006","unstructured":"Turk T, Pietruck F, Dolff S, Kribben A, Janssen OE, Mann K, Philipp T, Heemann U, Witzke O (2006) Repaglinide in the management of new-onset diabetes mellitus after renal transplantation. Am J Transplant 6(4):842\u2013846. \n                    https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01250.x","journal-title":"Am J Transplant"},{"issue":"4","key":"1137_CR76","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","volume":"20","author":"RE Soccio","year":"2014","unstructured":"Soccio RE, Chen ER, Lazar MA (2014) Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab 20(4):573\u2013591. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2014.08.005","journal-title":"Cell Metab"},{"issue":"7","key":"1137_CR77","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/01.TP.0000116393.98934.6F","volume":"77","author":"D Baldwin Jr","year":"2004","unstructured":"Baldwin D Jr, Duffin KE (2004) Rosiglitazone treatment of diabetes mellitus after solid organ transplantation. Transplantation 77(7):1009\u20131014","journal-title":"Transplantation"},{"issue":"12","key":"1137_CR78","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1111\/j.1600-6143.2004.00613.x","volume":"4","author":"P Luther","year":"2004","unstructured":"Luther P, Baldwin D Jr (2004) Pioglitazone in the management of diabetes mellitus after transplantation. Am J Transplant 4(12):2135\u20132138. \n                    https:\/\/doi.org\/10.1111\/j.1600-6143.2004.00613.x","journal-title":"Am J Transplant"},{"issue":"4","key":"1137_CR79","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1432-2277.2004.00076.x","volume":"18","author":"F Pietruck","year":"2005","unstructured":"Pietruck F, Kribben A, Van TN, Patschan D, Herget-Rosenthal S, Janssen O, Mann K, Philipp T, Witzke O (2005) Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation. Transpl Int 18(4):483\u2013486. \n                    https:\/\/doi.org\/10.1111\/j.1432-2277.2004.00076.x","journal-title":"Transpl Int"},{"issue":"10","key":"1137_CR80","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1097\/01.tp.0000181165.19788.95","volume":"80","author":"G Villanueva","year":"2005","unstructured":"Villanueva G, Baldwin D (2005) Rosiglitazone therapy of posttransplant diabetes mellitus. Transplantation 80(10):1402\u20131405","journal-title":"Transplantation"},{"issue":"2","key":"1137_CR81","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5500\/wjt.v6.i2.370","volume":"6","author":"KL Naylor","year":"2016","unstructured":"Naylor KL, Zou G, Leslie WD, Hodsman AB, Lam NN, McArthur E, Fraser LA, Knoll GA, Adachi JD, Kim SJ, Garg AX (2016) Risk factors for fracture in adult kidney transplant recipients. World J Transplant 6(2):370\u2013379. \n                    https:\/\/doi.org\/10.5500\/wjt.v6.i2.370","journal-title":"World J Transplant"},{"issue":"1","key":"1137_CR82","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/dom.13018","volume":"20","author":"ES Andersen","year":"2018","unstructured":"Andersen ES, Deacon CF, Holst JJ (2018) Do we know the true mechanism of action of the DPP-4 inhibitors? Diabetes Obes Metab 20(1):34\u201341. \n                    https:\/\/doi.org\/10.1111\/dom.13018","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl 1","key":"1137_CR83","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.4103\/2230-8210.119572","volume":"17","author":"D Sanyal","year":"2013","unstructured":"Sanyal D, Gupta S, Das P (2013) A retrospective study evaluating efficacy and safety of linagliptin in treatment of NODAT (in renal transplant recipients) in a real world setting. Indian J Endocrinol Metab 17(Suppl 1):S203\u2013S205. \n                    https:\/\/doi.org\/10.4103\/2230-8210.119572","journal-title":"Indian J Endocrinol Metab"},{"issue":"4","key":"1137_CR84","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/ndt\/gft536","volume":"29","author":"TA Strom Halden","year":"2014","unstructured":"Strom Halden TA, Asberg A, Vik K, Hartmann A, Jenssen T (2014) Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation. Nephrol Dial Transplant 29(4):926\u2013933. \n                    https:\/\/doi.org\/10.1093\/ndt\/gft536","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1137_CR85","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/ajt.12518","volume":"14","author":"M Haidinger","year":"2014","unstructured":"Haidinger M, Werzowa J, Hecking M, Antlanger M, Stemer G, Pleiner J, Kopecky C, Kovarik JJ, Doller D, Pacini G, Saemann MD (2014) Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation\u2013a randomized, double-blind, placebo-controlled trial. Am J Transplant 14(1):115\u2013123. \n                    https:\/\/doi.org\/10.1111\/ajt.12518","journal-title":"Am J Transplant"},{"issue":"12","key":"1137_CR86","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrendo.2012.140","volume":"8","author":"JJ Meier","year":"2012","unstructured":"Meier JJ (2012) GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol 8(12):728\u2013742. \n                    https:\/\/doi.org\/10.1038\/nrendo.2012.140","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"1137_CR87","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB, Committee LS, Investigators LT (2016) Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 375(4):311\u2013322. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1603827","journal-title":"N Engl J Med"},{"issue":"4","key":"1137_CR88","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2337\/dc15-2383","volume":"39","author":"TA Halden","year":"2016","unstructured":"Halden TA, Egeland EJ, Asberg A, Hartmann A, Midtvedt K, Khiabani HZ, Holst JJ, Knop FK, Hornum M, Feldt-Rasmussen B, Jenssen T (2016) GLP-1 restores altered insulin and glucagon secretion in posttransplantation diabetes. Diabetes Care 39(4):617\u2013624. \n                    https:\/\/doi.org\/10.2337\/dc15-2383","journal-title":"Diabetes Care"},{"issue":"10","key":"1137_CR89","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.2337\/dc13-1066","volume":"36","author":"NR Pinelli","year":"2013","unstructured":"Pinelli NR, Patel A, Salinitri FD (2013) Coadministration of liraglutide with tacrolimus in kidney transplant recipients: a case series. Diabetes Care 36(10):e171\u2013e172. \n                    https:\/\/doi.org\/10.2337\/dc13-1066","journal-title":"Diabetes Care"},{"issue":"3","key":"1137_CR90","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.transci.2016.10.002","volume":"55","author":"M Reddy","year":"2016","unstructured":"Reddy M, Tawfik B, Gavva C, Yates S, De Simone N, Hofmann SL, Rambally S, Sarode R (2016) Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency. Transfus Apheres Sci 55(3):364\u2013367. \n                    https:\/\/doi.org\/10.1016\/j.transci.2016.10.002","journal-title":"Transfus Apheres Sci"},{"issue":"4","key":"1137_CR91","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B, Investigators E-RO (2016) Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 375(4):323\u2013334. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1515920","journal-title":"N Engl J Med"},{"issue":"12","key":"1137_CR92","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrneph.2016.159","volume":"12","author":"K Hahn","year":"2016","unstructured":"Hahn K, Ejaz AA, Kanbay M, Lanaspa MA, Johnson RJ (2016) Acute kidney injury from SGLT2 inhibitors: potential mechanisms. Nat Rev Nephrol 12(12):711\u2013712. \n                    https:\/\/doi.org\/10.1038\/nrneph.2016.159","journal-title":"Nat Rev Nephrol"},{"key":"1137_CR93","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-018-1116-0","author":"R Puckrin","year":"2018","unstructured":"Puckrin R, Saltiel MP, Reynier P, Azoulay L, Yu OHY, Filion KB (2018) SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials. Acta Diabetol. \n                    https:\/\/doi.org\/10.1007\/s00592-018-1116-0","journal-title":"Acta Diabetol"},{"issue":"39","key":"1137_CR94","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Z, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WM, Vlachopoulos C, Wood DA, Zamorano JL, Authors\/Task Force M, Additional C (2016) 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J 37(39):2999\u20133058. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw272","journal-title":"Eur Heart J"},{"key":"1137_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd005019.pub4","author":"SC Palmer","year":"2014","unstructured":"Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF (2014) HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.cd005019.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"1137_CR96","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1161\/cir.0000000000000456","volume":"134","author":"BS Wiggins","year":"2016","unstructured":"Wiggins BS, Saseen JJ, Page RL, 2nd, Reed BN, Sneed K, Kostis JB, Lanfear D, Virani S, Morris PB, American Heart Association Clinical Pharmacology Committee of the Council on Clinical C, Council on H, Council on Quality of C, Outcomes R, Council on Functional G, Translational B (2016) Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association. Circulation 134(21):e468\u2013e495. \n                    https:\/\/doi.org\/10.1161\/cir.0000000000000456","journal-title":"Circulation"},{"issue":"7","key":"1137_CR97","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2337\/dc16-2258","volume":"40","author":"MF Eisenga","year":"2017","unstructured":"Eisenga MF, Zelle DM, Sloan JH, Gaillard C, Bakker SJL, Dullaart RPF (2017) High serum pcsk9 is associated with increased risk of new-onset diabetes after transplantation in renal transplant recipients. Diabetes Care 40(7):894\u2013901. \n                    https:\/\/doi.org\/10.2337\/dc16-2258","journal-title":"Diabetes Care"},{"issue":"5","key":"1137_CR98","doi-asserted-by":"publisher","first-page":"e0154683","DOI":"10.1371\/journal.pone.0154683","volume":"11","author":"E Han","year":"2016","unstructured":"Han E, Yun Y, Kim G, Lee YH, Wang HJ, Lee BW, Cha BS, Kim BS, Kang ES (2016) Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia. PLoS ONE 11(5):e0154683. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0154683","journal-title":"PLoS ONE"},{"key":"1137_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd005282.pub3","author":"AK Lim","year":"2016","unstructured":"Lim AK, Manley KJ, Roberts MA, Fraenkel MB (2016) Fish oil for kidney transplant recipients. Cochrane Database System Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.cd005282.pub3","journal-title":"Cochrane Database System Rev"},{"issue":"3","key":"1137_CR100","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/ndt\/gft321","volume":"29","author":"F Verbeke","year":"2014","unstructured":"Verbeke F, Lindley E, Van Bortel L, Vanholder R, London G, Cochat P, Wiecek A, Fouque D, Van Biesen W (2014) A European Renal best practice (ERBP) position statement on the kidney disease: improving global outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant 29(3):490\u2013496. \n                    https:\/\/doi.org\/10.1093\/ndt\/gft321","journal-title":"Nephrol Dial Transplant"},{"key":"1137_CR101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd003598.pub2","author":"NB Cross","year":"2009","unstructured":"Cross NB, Webster AC, Masson P, O\u2019Connell PJ, Craig JC (2009) Antihypertensive treatment for kidney transplant recipients. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.cd003598.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1137_CR102","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/TP.0000000000001140","volume":"100","author":"NB Cross","year":"2016","unstructured":"Cross NB, Webster AC (2016) Angiotensin-converting enzyme inhibitors-beneficial effects seen in many patient groups may not extend to kidney transplant recipients. Transplantation 100(3):472\u2013473. \n                    https:\/\/doi.org\/10.1097\/TP.0000000000001140","journal-title":"Transplantation"},{"issue":"12","key":"1137_CR103","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s40264-015-0339-z","volume":"38","author":"N Fathallah","year":"2015","unstructured":"Fathallah N, Slim R, Larif S, Hmouda H, Ben Salem C (2015) Drug-induced hyperglycaemia and diabetes. Drug Saf 38(12):1153\u20131168. \n                    https:\/\/doi.org\/10.1007\/s40264-015-0339-z","journal-title":"Drug Saf"},{"issue":"4","key":"1137_CR104","doi-asserted-by":"publisher","first-page":"616","DOI":"10.2215\/CJN.07501009","volume":"5","author":"HA Bergrem","year":"2010","unstructured":"Bergrem HA, Valderhaug TG, Hartmann A, Hjelmesaeth J, Leivestad T, Bergrem H, Jenssen T (2010) Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy. Clin J Am Soc Nephrol CJASN 5(4):616\u2013622. \n                    https:\/\/doi.org\/10.2215\/CJN.07501009","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"10","key":"1137_CR105","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.2337\/dc13-0428","volume":"36","author":"HA Chakkera","year":"2013","unstructured":"Chakkera HA, Chang YH, Ayub A, Gonwa TA, Weil EJ, Knowler WC (2013) Validation of a pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care 36(10):2881\u20132886. \n                    https:\/\/doi.org\/10.2337\/dc13-0428","journal-title":"Diabetes Care"},{"issue":"10","key":"1137_CR106","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.2337\/dc11-0752","volume":"34","author":"HA Chakkera","year":"2011","unstructured":"Chakkera HA, Weil EJ, Swanson CM, Dueck AC, Heilman RL, Reddy KS, Hamawi K, Khamash H, Moss AA, Mulligan DC, Katariya N, Knowler WC (2011) Pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care 34(10):2141\u20132145. \n                    https:\/\/doi.org\/10.2337\/dc11-0752","journal-title":"Diabetes Care"},{"issue":"7","key":"1137_CR107","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/TP.0b013e31820f0877","volume":"91","author":"S Caillard","year":"2011","unstructured":"Caillard S, Eprinchard L, Perrin P, Braun L, Heibel F, Moreau F, Kessler L, Moulin B (2011) Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematic screening by oral glucose tolerance test. Transplantation 91(7):757\u2013764. \n                    https:\/\/doi.org\/10.1097\/TP.0b013e31820f0877","journal-title":"Transplantation"},{"issue":"8","key":"1137_CR108","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/TP.0b013e3181f1543c","volume":"90","author":"ND Bayer","year":"2010","unstructured":"Bayer ND, Cochetti PT, Anil Kumar MS, Teal V, Huan Y, Doria C, Bloom RD, Rosas SE (2010) Association of metabolic syndrome with development of new-onset diabetes after transplantation. Transplantation 90(8):861\u2013866. \n                    https:\/\/doi.org\/10.1097\/TP.0b013e3181f1543c","journal-title":"Transplantation"},{"issue":"3","key":"1137_CR109","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2337\/dc11-2071","volume":"35","author":"E Rodrigo","year":"2012","unstructured":"Rodrigo E, Santos L, Pinera C, Millan JC, Quintela ME, Toyos C, Allende N, Gomez-Alamillo C, Arias M (2012) Prediction at first year of incident new-onset diabetes after kidney transplantation by risk prediction models. Diabetes Care 35(3):471\u2013473. \n                    https:\/\/doi.org\/10.2337\/dc11-2071","journal-title":"Diabetes Care"},{"issue":"Suppl 3","key":"1137_CR110","first-page":"138","volume":"14","author":"N Aksoy","year":"2016","unstructured":"Aksoy N (2016) Weight gain after kidney transplant. Exp Clin Transplant 14(Suppl 3):138\u2013140","journal-title":"Exp Clin Transplant"},{"issue":"2","key":"1137_CR111","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1194\/jlr.D020321","volume":"53","author":"E Fabbrini","year":"2012","unstructured":"Fabbrini E, Magkos F, Conte C, Mittendorfer B, Patterson BW, Okunade AL, Klein S (2012) Validation of a novel index to assess insulin resistance of adipose tissue lipolytic activity in obese subjects. J Lipid Res 53(2):321\u2013324. \n                    https:\/\/doi.org\/10.1194\/jlr.D020321","journal-title":"J Lipid Res"},{"issue":"1","key":"1137_CR112","doi-asserted-by":"publisher","first-page":"e000283","DOI":"10.1136\/bmjdrc-2016-000283","volume":"5","author":"MC Oste","year":"2017","unstructured":"Oste MC, Corpeleijn E, Navis GJ, Keyzer CA, Soedamah-Muthu SS, van den Berg E, Postmus D, de Borst MH, Kromhout D, Bakker SJ (2017) Mediterranean style diet is associated with low risk of new-onset diabetes after renal transplantation. BMJ Open Diabetes Res Care 5(1):e000283. \n                    https:\/\/doi.org\/10.1136\/bmjdrc-2016-000283","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"3","key":"1137_CR113","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/TP.0b013e3181605ebf","volume":"85","author":"A Sharif","year":"2008","unstructured":"Sharif A, Moore R, Baboolal K (2008) Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia. Transplantation 85(3):353\u2013358. \n                    https:\/\/doi.org\/10.1097\/TP.0b013e3181605ebf","journal-title":"Transplantation"},{"key":"1137_CR114","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1471-2369-15-148","volume":"15","author":"KJ Ryan","year":"2014","unstructured":"Ryan KJ, Casas JM, Mash LE, McLellan SL, Lloyd LE, Stinear JW, Plank LD, Collins MG (2014) The effect of intensive nutrition interventions on weight gain after kidney transplantation: protocol of a randomised controlled trial. BMC Nephrol 15:148. \n                    https:\/\/doi.org\/10.1186\/1471-2369-15-148","journal-title":"BMC Nephrol"},{"issue":"4","key":"1137_CR115","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.trre.2016.07.006","volume":"30","author":"B Camilleri","year":"2016","unstructured":"Camilleri B, Bridson JM, Sharma A, Halawa A (2016) From chronic kidney disease to kidney transplantation: the impact of obesity and its treatment modalities. Transplant Rev 30(4):203\u2013211. \n                    https:\/\/doi.org\/10.1016\/j.trre.2016.07.006","journal-title":"Transplant Rev"},{"issue":"3","key":"1137_CR116","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.transproceed.2015.12.074","volume":"48","author":"JH Chen","year":"2016","unstructured":"Chen JH, Lee CH, Chang CM, Yin WY (2016) Successful management of new-onset diabetes mellitus and obesity with the use of laparoscopic sleeve gastrectomy after kidney transplantation-a case report. Transpl Proc 48(3):938\u2013939. \n                    https:\/\/doi.org\/10.1016\/j.transproceed.2015.12.074","journal-title":"Transpl Proc"},{"issue":"6","key":"1137_CR117","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.ajkd.2017.08.006","volume":"70","author":"SJ Kim","year":"2017","unstructured":"Kim SJ (2017) Serum uric acid levels and kidney transplant outcomes: Cause, consequence, or confounded? Am J Kidney Dis 70(6):752\u2013753. \n                    https:\/\/doi.org\/10.1053\/j.ajkd.2017.08.006","journal-title":"Am J Kidney Dis"},{"key":"1137_CR118","doi-asserted-by":"publisher","first-page":"350","DOI":"10.12659\/AOT.896821","volume":"21","author":"N Pagonas","year":"2016","unstructured":"Pagonas N, Kor S, Seibert FS, Giese A, Zidek W, Reinke P, Babel N, Bauer F, Westhoff TH (2016) Effects of treatment of asymptomatic hyperuricemia on graft survival and mortality in kidney transplant recipients. Ann Transplant 21:350\u2013359. \n                    https:\/\/doi.org\/10.12659\/AOT.896821","journal-title":"Ann Transplant"},{"issue":"9","key":"1137_CR119","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/tri.12287","volume":"27","author":"S Laecke Van","year":"2014","unstructured":"Van Laecke S, Nagler EV, Taes Y, Van Biesen W, Peeters P, Vanholder R (2014) The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial. Transpl Int 27(9):895\u2013902. \n                    https:\/\/doi.org\/10.1111\/tri.12287","journal-title":"Transpl Int"},{"key":"1137_CR120","doi-asserted-by":"publisher","first-page":"524","DOI":"10.12659\/AOT.903439","volume":"22","author":"S Laecke Van","year":"2017","unstructured":"Van Laecke S, Caluwe R, Huybrechts I, Nagler EV, Vanholder R, Peeters P, Van Vlem B, Van Biesen W (2017) Effect of magnesium supplements on insulin secretion after kidney transplantation: a randomized controlled trial. Ann Transplant 22:524\u2013531","journal-title":"Ann Transplant"},{"key":"1137_CR121","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/1745-6215-15-430","volume":"15","author":"M Courbebaisse","year":"2014","unstructured":"Courbebaisse M, Alberti C, Colas S, Prie D, Souberbielle JC, Treluyer JM, Thervet E (2014) VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial. Trials 15:430. \n                    https:\/\/doi.org\/10.1186\/1745-6215-15-430","journal-title":"Trials"},{"issue":"3","key":"1137_CR122","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0041-1345(00)00898-8","volume":"32","author":"M Gursoy","year":"2000","unstructured":"Gursoy M, Koksal R, Karavelioglu D, Colak T, Gur G, Ozdemir N, Boyacioglu S, Bilgin N (2000) Pretransplantation alpha-interferon therapy and the effect of hepatitis C virus infection on kidney allograft recipients. Transpl Proc 32(3):580\u2013582","journal-title":"Transpl Proc"},{"issue":"7","key":"1137_CR123","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/ndt\/gfm011","volume":"22","author":"N Kamar","year":"2007","unstructured":"Kamar N, Mariat C, Delahousse M, Dantal J, Al Najjar A, Cassuto E, Lefrancois N, Cointault O, Touchard G, Villemain F, Di Giambattista F, Benhamou PY, Diapason Study G (2007) Diabetes mellitus after kidney transplantation: a French multicentre observational study. Nephrol Dial Transplant 22(7):1986\u20131993. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfm011","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"1137_CR124","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","volume":"10","author":"A Humar","year":"2010","unstructured":"Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, Abramowicz D, Jardine AG, Voulgari AT, Ives J, Hauser IA, Peeters P (2010) The efficacy and safety of 200\u00a0days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant 10(5):1228\u20131237. \n                    https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03074.x","journal-title":"Am J Transplant"},{"issue":"1","key":"1137_CR125","doi-asserted-by":"publisher","first-page":"10277","DOI":"10.1038\/s41598-017-10471-2","volume":"7","author":"M Bhat","year":"2017","unstructured":"Bhat M, Pasini E, Copeland J, Angeli M, Husain S, Kumar D, Renner E, Teterina A, Allard J, Guttman DS, Humar A (2017) Impact of immunosuppression on the metagenomic composition of the intestinal microbiome: a systems biology approach to post-transplant diabetes. Sci Rep 7(1):10277. \n                    https:\/\/doi.org\/10.1038\/s41598-017-10471-2","journal-title":"Sci Rep"},{"issue":"3","key":"1137_CR126","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/TP.0b013e318276a20e","volume":"95","author":"J Werzowa","year":"2013","unstructured":"Werzowa J, Hecking M, Haidinger M, Lechner F, Doller D, Pacini G, Stemer G, Pleiner J, Frantal S, Saemann MD (2013) Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial. Transplantation 95(3):456\u2013462. \n                    https:\/\/doi.org\/10.1097\/TP.0b013e318276a20e","journal-title":"Transplantation"},{"issue":"8","key":"1137_CR127","doi-asserted-by":"publisher","first-page":"e016813","DOI":"10.1136\/bmjopen-2017-016813","volume":"7","author":"B Alnasrallah","year":"2017","unstructured":"Alnasrallah B, Pilmore H, Manley P (2017) Protocol for a pilot randomised controlled trial of metformin in pre-diabetes after kidney transplantation: the transplantation and diabetes (transdiab) study. BMJ Open 7(8):e016813. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2017-016813","journal-title":"BMJ Open"},{"issue":"7520","key":"1137_CR128","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","volume":"331","author":"AC Webster","year":"2005","unstructured":"Webster AC, Woodroffe RC, Taylor RS, Chapman JR, Craig JC (2005) Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ 331(7520):810. \n                    https:\/\/doi.org\/10.1136\/bmj.38569.471007.AE","journal-title":"BMJ"},{"issue":"3","key":"1137_CR129","doi-asserted-by":"publisher","first-page":"494","DOI":"10.2215\/CJN.08630811","volume":"7","author":"MD Rizzari","year":"2012","unstructured":"Rizzari MD, Suszynski TM, Gillingham KJ, Dunn TB, Ibrahim HN, Payne WD, Chinnakotla S, Finger EB, Sutherland DE, Kandaswamy R, Najarian JS, Pruett TL, Kukla A, Spong R, Matas AJ (2012) Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation. Clin J Am Soc Nephrol CJASN 7(3):494\u2013503. \n                    https:\/\/doi.org\/10.2215\/CJN.08630811","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"10","key":"1137_CR130","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1097\/TP.0000000000001756","volume":"101","author":"OK Serrano","year":"2017","unstructured":"Serrano OK, Kandaswamy R, Gillingham K, Chinnakotla S, Dunn TB, Finger E, Payne W, Ibrahim H, Kukla A, Spong R, Issa N, Pruett TL, Matas A (2017) Rapid discontinuation of prednisone in kidney transplant recipients: 15-year outcomes from the University of Minnesota. Transplantation 101(10):2590\u20132598. \n                    https:\/\/doi.org\/10.1097\/TP.0000000000001756","journal-title":"Transplantation"},{"issue":"7","key":"1137_CR131","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1111\/ajt.13247","volume":"15","author":"JD Pirsch","year":"2015","unstructured":"Pirsch JD, Henning AK, First MR, Fitzsimmons W, Gaber AO, Reisfield R, Shihab F, Woodle ES (2015) New-Onset diabetes after transplantation: results from a double-blind early corticosteroid withdrawal trial. Am J Transplant 15(7):1982\u20131990. \n                    https:\/\/doi.org\/10.1111\/ajt.13247","journal-title":"Am J Transplant"},{"issue":"1","key":"1137_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/jeb.040469","volume":"213","author":"K Knight","year":"2010","unstructured":"Knight K, Hoppeler H (2010) Bill harvey retires. J Exp Biol 213(1):1. \n                    https:\/\/doi.org\/10.1242\/jeb.040469","journal-title":"J Exp Biol"},{"issue":"1","key":"1137_CR133","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12916-016-0772-6","volume":"15","author":"MC Haller","year":"2017","unstructured":"Haller MC, Kammer M, Kainz A, Baer HJ, Heinze G, Oberbauer R (2017) Steroid withdrawal after renal transplantation: a retrospective cohort study. BMC Med 15(1):8. \n                    https:\/\/doi.org\/10.1186\/s12916-016-0772-6","journal-title":"BMC Med"},{"issue":"8","key":"1137_CR134","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1097\/TP.0000000000001453","volume":"101","author":"G Mourad","year":"2017","unstructured":"Mourad G, Glyda M, Albano L, Viklicky O, Merville P, Tyden G, Mourad M, Lohmus A, Witzke O, Christiaans MHL, Brown MW, Undre N, Kazeem G, Kuypers DRJ, Advagraf-based immunosuppression regimen examining new onset diabetes mellitus in kidney transplant recipients study i (2017) Incidence of posttransplantation diabetes mellitus in de novo kidney transplant recipients receiving prolonged-release tacrolimus-based immunosuppression with 2 different corticosteroid minimization strategies: ADVANCE, a randomized controlled trial. Transplantation 101(8):1924\u20131934. \n                    https:\/\/doi.org\/10.1097\/TP.0000000000001453","journal-title":"Transplantation"},{"key":"1137_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd005632.pub3","author":"MC Haller","year":"2016","unstructured":"Haller MC, Royuela A, Nagler EV, Pascual J, Webster AC (2016) Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.cd005632.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"1137_CR136","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/ndt\/gfx074","volume":"32","author":"TM Snowsill","year":"2017","unstructured":"Snowsill TM, Moore J, Mujica Mota RE, Peters JL, Jones-Hughes TL, Huxley NJ, Coelho HF, Haasova M, Cooper C, Lowe JA, Varley-Campbell JL, Crathorne L, Allwood MJ, Anderson R (2017) Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation. Nephrol Dial Transplant 32(7):1251\u20131259. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfx074","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"1137_CR137","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1016\/j.transproceed.2012.09.066","volume":"44","author":"F Batista","year":"2012","unstructured":"Batista F, Auyanet I, Torregrosa JV, Oppenheimer F (2012) Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation. Transpl Proc 44(9):2582\u20132584. \n                    https:\/\/doi.org\/10.1016\/j.transproceed.2012.09.066","journal-title":"Transpl Proc"},{"issue":"11","key":"1137_CR138","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1681\/ASN.2010111160","volume":"22","author":"A Sharif","year":"2011","unstructured":"Sharif A, Shabir S, Chand S, Cockwell P, Ball S, Borrows R (2011) Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation. J Am Soc Nephrol JASN 22(11):2107\u20132118. \n                    https:\/\/doi.org\/10.1681\/ASN.2010111160","journal-title":"J Am Soc Nephrol JASN"},{"key":"1137_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd006750.pub2","author":"KM Karpe","year":"2017","unstructured":"Karpe KM, Talaulikar GS, Walters GD (2017) Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.cd006750.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1137_CR140","doi-asserted-by":"publisher","first-page":"496974","DOI":"10.1155\/2013\/496974","volume":"2013","author":"M Veroux","year":"2013","unstructured":"Veroux M, Tallarita T, Corona D, Sinagra N, Giaquinta A, Zerbo D, Guerrieri C, D\u2019Assoro A, Cimino S, Veroux P (2013) Conversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation. Clin Dev Immunol 2013:496974. \n                    https:\/\/doi.org\/10.1155\/2013\/496974","journal-title":"Clin Dev Immunol"},{"issue":"10","key":"1137_CR141","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1681\/ASN.2005050487","volume":"16","author":"A Teutonico","year":"2005","unstructured":"Teutonico A, Schena PF, Di Paolo S (2005) Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol JASN 16(10):3128\u20133135. \n                    https:\/\/doi.org\/10.1681\/ASN.2005050487","journal-title":"J Am Soc Nephrol JASN"},{"key":"1137_CR142","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13024","author":"F Kalble","year":"2017","unstructured":"Kalble F, Seckinger J, Schaier M, Morath C, Schwenger V, Zeier M, Sommerer C (2017) Switch to an everolimus-facilitated cyclosporine A sparing immunosuppression improves glycemic control in selected kidney transplant recipients. Clin Transplant. \n                    https:\/\/doi.org\/10.1111\/ctr.13024","journal-title":"Clin Transplant"},{"key":"1137_CR143","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd010699.pub2","author":"P Masson","year":"2014","unstructured":"Masson P, Henderson L, Chapman JR, Craig JC, Webster AC (2014) Belatacept for kidney transplant recipients. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.cd010699.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"1137_CR144","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/j.1600-6143.2011.03550.x","volume":"11","author":"A Sharif","year":"2011","unstructured":"Sharif A (2011) Should metformin be our antiglycemic agent of choice post-transplantation? Am J Transplant 11(7):1376\u20131381. \n                    https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03550.x","journal-title":"Am J Transplant"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-018-1137-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-018-1137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-018-1137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T03:26:19Z","timestamp":1554348379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-018-1137-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":144,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1137"],"URL":"https:\/\/doi.org\/10.1007\/s00592-018-1137-8","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,4]]},"assertion":[{"value":"5 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No studies involving human participants nor experimental animals were conducted by the authors specifically for the preparation of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard statement"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}